This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 May 8;375(9726):1605; author reply 1606-7.

doi: 10.1016/S0140-6736(10)60694-0.

Procalcitonin in intensive care units: the PRORATA trial

Djamel Mokart, Marc Leone

PMID: 20452515
DOI: 10.1016/S0140-6736(10)60694-0

Comment

Procalcitonin in intensive care units: the PRORATA trial

Djamel Mokart et al. Lancet. 2010.

. 2010 May 8;375(9726):1605; author reply 1606-7.

doi: 10.1016/S0140-6736(10)60694-0.

Authors

Djamel Mokart, Marc Leone

PMID: 20452515
DOI: 10.1016/S0140-6736(10)60694-0

No abstract available

PubMed Disclaimer

Comment on

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.
Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M; PRORATA trial group. Bouadma L, et al. Lancet. 2010 Feb 6;375(9713):463-74. doi: 10.1016/S0140-6736(09)61879-1. Epub 2010 Jan 25. Lancet. 2010. PMID: 20097417 Clinical Trial.

Similar articles

Procalcitonin in intensive care units: the PRORATA trial.
Tarnow-Mordi W, Gebski V. Tarnow-Mordi W, et al. Lancet. 2010 May 8;375(9726):1605; author reply 1606-7. doi: 10.1016/S0140-6736(10)60695-2. Lancet. 2010. PMID: 20452513 No abstract available.
Procalcitonin in intensive care units: the PRORATA trial.
Gibot S. Gibot S. Lancet. 2010 May 8;375(9726):1605-6; author reply 1606-7. doi: 10.1016/S0140-6736(10)60696-4. Lancet. 2010. PMID: 20452514 No abstract available.
Procalcitonin in intensive care units: the PRORATA trial.
Landman GW, Kleefstra N. Landman GW, et al. Lancet. 2010 May 8;375(9726):1606; author reply 1606-7. doi: 10.1016/S0140-6736(10)60697-6. Lancet. 2010. PMID: 20452516 No abstract available.
[Procalcitonin as a biomarker in infections].
Christ-Crain M. Christ-Crain M. Praxis (Bern 1994). 2007 Jun 20;96(25-26):1017-21. doi: 10.1024/1661-8157.96.25.1017. Praxis (Bern 1994). 2007. PMID: 17639964 Review. German. No abstract available.
[Procalcitonin: a reliable marker for the diagnosis and monitoring of the course of bacterial infection].
Holub M, Rozsypal H, Chalupa P. Holub M, et al. Klin Mikrobiol Infekc Lek. 2008 Dec;14(6):201-8. Klin Mikrobiol Infekc Lek. 2008. PMID: 19214953 Review. Czech.

See all similar articles

Cited by

The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia.
Guo S, Mao X, Liang M. Guo S, et al. Respir Res. 2018 Oct 1;19(1):193. doi: 10.1186/s12931-018-0877-x. Respir Res. 2018. PMID: 30285748 Free PMC article.
Accuracy of procalcitonin for diagnosing sepsis in adult patients admitted to the emergency department: a systematic review and meta-analysis.
Zaki HA, Bensliman S, Bashir K, Iftikhar H, Fayed MH, Salem W, Elmoheen A, Yigit Y. Zaki HA, et al. Syst Rev. 2024 Jan 22;13(1):37. doi: 10.1186/s13643-023-02432-w. Syst Rev. 2024. PMID: 38254218 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information